Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Shares of Globus Medical ticked up nearly 2% after the orthopedic implant maker reported preliminary 4th-quarter results that topped expectations.
Audubon, Pa.-based Globus said it expects Q4 revenues to come in at roughly $142.6 million, ahead of the consensus expectation on Wall Street for $139.2 million. Full-year sales are pegged at $544.7 million, again ahead of The Street’s $541.1 million forecast. Read more
The CEOs of Medtronic and International Business Machine unveiled a the fruits of the project they’ve been working on since last April, combining the IBM Watson artificial intelligence platform with Medtronic’s insulin management devices.
Medtronic CEO Omar Ishrak joined IBM chief Ginni Rometty at the Consumer Electronics Show in Las Vegas to unveil the app, which is designed to detect low blood sugar events before they happen. Read more
BiO2 Medical said that it raised a $9 million Series D round for its Angel catheter, after concluding its pivotal clinical trial a year ahead of schedule.
The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. Read more